Skye Bioscience Inc (SKYE)

[Vinpat]

I think GW is the product of the media and being what is perceived as first in. We'll see what that means for them. I think they've floundered trying to figure out how to get there and they've executed as far as shareholders are concerned but the only way I see them being relevant long term is if they acquire a Nemus or someone else. I think they'll have to do acquistions at some point.

The plant is only relevant for research purposes. I think GW is using synthetics for their drugs in clinicals now but haven't paid attention. If they're not then that's a drawback. I thought I read that the FDA will only approve synthetics but they might make an exception for GW for an orphan drug. UofM has taken advantage of their ability to grow by being able to do more research than probably everyone else combined. From that, they have developed a library of IP that can be advanced for commercial purposes. Nemus has started with what they think will bring the most value the fastest. From there, they can keep digging into the vault and keep adding value. That's if it ever gets to that point and Nemus isn't bought out.

Once they get into Phase II, there's going to be a lot of interest from the big guys if not sooner.